Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study on Assessment of the Soluble Urokinase Plasminogen Activator Receptor in Adult Patients With Covid-19

NCT04590794 is registered in ClinicalTrials.gov with University of Thessaly as lead sponsor.

NCT NCT04590794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04590794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study on Assessment of the Soluble Urokinase Plasminogen Activator Receptor in Adult Patients With Covid-19
Lead sponsor
University of Thessaly
Phase
Observational
Overall status
Completed
Start date
October 11, 2020
Completion date
June 8, 2021
Enrollment
767 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19